Dose-dependent effects of Nrf2 on the epidermis in chronic skin inflammation

Dose-dependent effects of Nrf2 on the epidermis in chronic skin inflammation

Saved in:

Bibliographic Details
Main Authors:	Michael Koch, Luca Ferrarese, Maya Ben-Yehuda Greenwald, Sabine Werner
Format:	Article
Language:	English
Published:	The Company of Biologists 2025-01-01
Series:	Disease Models & Mechanisms
Subjects:	skin atopic dermatitis keratinocyte nrf2 fgf cytoprotection
Online Access:	http://dmm.biologists.org/content/18/1/dmm052126
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An Overview of the Skin Microbiome, the Potential for Pathogen Shift, and Dysbiosis in Common Skin Pathologies
by: Anita Smith, et al.
Published: (2025-01-01)

Skin Microbiota: Mediator of Interactions Between Metabolic Disorders and Cutaneous Health and Disease
by: Magdalini Kreouzi, et al.
Published: (2025-01-01)

A multi-strain human skin microbiome model provides a testbed for disease modeling
by: Angela L. Maloney, et al.
Published: (2025-02-01)

Restorative effects of camellia oil on the skin-barrier function in a model of DNCB-induced atopic dermatitis
by: Shicheng Jiao, et al.
Published: (2025-01-01)

Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study
by: Hyun Ji Lee, et al.
Published: (2025-02-01)

Effective and safe surgery for keratinocyte skin cancer in the elderly over 80 years of age: a single-institution retrospective study of 345 patients over one year
by: Luca D. Fontana, et al.
Published: (2025-12-01)

The management of severe eczema in pregnancy
by: E Keeling, et al.
Published: (2025-01-01)

Effectiveness and Safety of Dupilumab and Tralokinumab for Treating Atopic Dermatitis and Pruritic Skin Disorders in Oncological Patients: A Narrative Review
by: Lauletta G, et al.
Published: (2025-01-01)

FGF21 and APOA1 mRNA-based therapies for the treatment of experimental acute pancreatitis
by: Amaya Lopez-Pascual, et al.
Published: (2025-01-01)

Application of ectoine in diseases of the skin and mucous membranes
by: Piotr Kuna, et al.
Published: (2024-06-01)

Culture dependent and independent approaches reveal the role of specific bacteria in human skin aging
by: Jing‐jing Xia, et al.
Published: (2024-12-01)

Microneedle-Based Approaches for Skin Disease Treatment
by: Yanhua Han, et al.
Published: (2025-02-01)

Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
by: Mengmeng Li, et al.
Published: (2025-02-01)

Determining atopic dermatitis adult patients’ preferences regarding novel systemic treatment
by: Monika Suszynska, et al.
Published: (2025-01-01)

Patients’ preferences on atopic dermatitis skincare and social media use: a qualitative study
by: Roxana Mazilu, et al.
Published: (2025-02-01)

Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life
by: Andrew Blauvelt, et al.
Published: (2022-07-01)

Unmet needs in atopic dermatitis management: an expert consensus
by: Annalisa Patrizi, et al.
Published: (2022-07-01)

Mistakes in the diagnosis and treatment of atopic dermatitis
by: Monika Marko, et al.
Published: (2024-02-01)

The assessment of the facial skin microbiota in patients with seborrheic dermatitis and metabolic syndrome
by: Kristina Yu. Molodykh, et al.
Published: (2024-12-01)

Editorial: Impact of the innate and adaptive immune system in driving type 1 inflammatory skin disease
by: Mark Mellett, et al.
Published: (2025-02-01)

Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database
by: Liu J, et al.
Published: (2025-02-01)

Is the Increase in Tumour Markers and Hashimoto’s Thyroiditis an Incidental Event During Dupilumab Treatment? A Case Report
by: Kesheng Lin, et al.
Published: (2025-02-01)

Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study
by: Filip Rob, et al.
Published: (2025-12-01)

Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index
by: Gabriele Di Lorenzo, et al.
Published: (2003-01-01)

Scratch Scoring by a Sheet-shaped Body Vibrometer in Nocturnal Sleep: A Pilot Study Compared with Infrared Video Recording
by: Saori Toyota, et al.
Published: (2025-01-01)

Hydrolyzed Collagen from Salmon Skin Increases the Migration and Filopodia Formation of Skin Keratinocytes by Activation of FAK/Src Pathway
by: Wanwipha Woonnoi, et al.
Published: (2021-09-01)

Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumab
by: Eri Uchiyama, et al.
Published: (2025-01-01)

Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD)
by: Marjolein de Bruin-Weller, et al.
Published: (2022-07-01)

Patients With Isolated Nail Psoriasis Are at Increased Risk for Asthma Compared to Controls in a Retrospective Cohort Study at a Single Academic Institution
by: Rachel C Hill, et al.
Published: (2025-01-01)

Atopic dermatitis in childhood and pubertal development: A nationwide cohort studyCapsule Summary
by: Camilla Lomholt Kjersgaard, MD, et al.
Published: (2025-04-01)

Safety of Dupilumab Therapy for Atopic Dermatitis during Pregnancy: A Systematic Review and Meta-analysis
by: Verónica Sánchez-García, et al.
Published: (2025-02-01)

Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications
by: Ahmad Vafaeian, et al.
Published: (2025-02-01)

A Comparative Study to Evaluate the Effectiveness between Synergic Activities of 0.1% Polyhexanide and Rigenase® (Fitostimoline® Plus spray) versus a Hydrating Formulation for the Topical Management of Rubbing Injuries Secondary to Atopic Dermatitis
by: Eugenia Veronica Di Brizzi, et al.
Published: (2025-01-01)

Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre Study
by: Stamatios Gregoriou, et al.
Published: (2025-01-01)

Comparative study of mouse models of atopic dermatitis
by: Siqi Ye, et al.
Published: (2025-01-01)

Ablation of the deubiquitinating enzyme cylindromatosis (CYLD) augments STAT1-mediated M1 macrophage polarization and fosters Staphylococcus aureus control
by: Christina Schmidt, et al.
Published: (2025-01-01)

Inborn Errors of Immunity Presenting with Early-Onset Severe Atopy
by: Nipat Chuleerarux, et al.
Published: (2025-01-01)

Allergen immunotherapy in atopic dermatitis
by: Agnieszka Bogacz-Piaseczyńska, et al.
Published: (2024-08-01)

The role of exogenous histamine in atopic dermatitis flare-ups
by: Zofia Kowalska, et al.
Published: (2024-08-01)

Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
by: Ga Hee Jeong, et al.
Published: (2025-01-01)